AU2828795A - Monoclonal antibodies for the reduction of anti-xenogeneic immune responses - Google Patents
Monoclonal antibodies for the reduction of anti-xenogeneic immune responsesInfo
- Publication number
- AU2828795A AU2828795A AU28287/95A AU2828795A AU2828795A AU 2828795 A AU2828795 A AU 2828795A AU 28287/95 A AU28287/95 A AU 28287/95A AU 2828795 A AU2828795 A AU 2828795A AU 2828795 A AU2828795 A AU 2828795A
- Authority
- AU
- Australia
- Prior art keywords
- reduction
- monoclonal antibodies
- immune responses
- xenogeneic immune
- xenogeneic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26148394A | 1994-06-17 | 1994-06-17 | |
PCT/US1995/007556 WO1995035120A1 (fr) | 1994-06-17 | 1995-06-14 | Anticorps monoclonaux destines a reduire les reactions immunes anti-heterologues |
US261483 | 1999-02-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2828795A true AU2828795A (en) | 1996-01-15 |
Family
ID=22993501
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU28287/95A Abandoned AU2828795A (en) | 1994-06-17 | 1995-06-14 | Monoclonal antibodies for the reduction of anti-xenogeneic immune responses |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2828795A (fr) |
WO (1) | WO1995035120A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6197294B1 (en) | 1998-10-26 | 2001-03-06 | Neurotech S.A. | Cell surface molecule-induced macrophage activation |
CA2571710A1 (fr) | 2004-06-24 | 2006-11-02 | Nicholas Valiante | Immuno-potentialisateurs a petites molecules et analyses visant a detecter leur presence |
US9420770B2 (en) | 2009-12-01 | 2016-08-23 | Indiana University Research & Technology Corporation | Methods of modulating thrombocytopenia and modified transgenic pigs |
-
1995
- 1995-06-14 AU AU28287/95A patent/AU2828795A/en not_active Abandoned
- 1995-06-14 WO PCT/US1995/007556 patent/WO1995035120A1/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1995035120A1 (fr) | 1995-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4042195A (en) | Anti-alphaV-integrin monoclonal antibody | |
IL128406A0 (en) | Monoclonal antibodies | |
EP0692536A3 (fr) | Proteine induisant la production d'interféron-gamma et anticorps monoclonal spécifique de celle-ci | |
AU5869596A (en) | Anti-gp130 monoclonal antibodies | |
PT837927E (pt) | Anticorpos contra cd80 | |
AU1462300A (en) | Human pan-hcv human monoclonal antibodies | |
GB9422383D0 (en) | Antibodies | |
AU1704099A (en) | Monoclonal human natural antibodies | |
AU4618193A (en) | Humanized antibodies | |
AU1289795A (en) | Monoclonal antibodies specific for human interleukin-5 | |
AU5365296A (en) | Human monoclonal antibody against lung carcinoma | |
EP0870826A4 (fr) | Nouvelle proteine et anticorps monoclonal specifique a cette derniere | |
EP0809806A4 (fr) | Anticorps monoclonaux contre des antigenes de surface de cellules osteogenes | |
AU2391195A (en) | Lymphocyte activation antigens and antibodies thereto | |
AU6080794A (en) | Antibodies directed against binding-associated epitopes | |
AU5686698A (en) | Methods for the production of chicken monoclonal antibodies | |
AU6702998A (en) | Anti-alphabeta3 humanized monoclonal antibodies | |
AU1423892A (en) | Monoclonal antibodies directed towards mycobacterial antigens | |
EP0977590A4 (fr) | Anticorps monoclonaux humains | |
EP0909278A4 (fr) | Immunoglobuline g liee a la nephropathie et anticorps contre celle-ci | |
PL320610A1 (en) | Fragments of monoclonal antibodies of immunosuppressive activity | |
AU5688596A (en) | Anti-cd14 antibodies for use in the induction of il-10 secre tion | |
AU3923293A (en) | Human monoclonal antibodies and methods for human monoclonal antibody production | |
AU2828795A (en) | Monoclonal antibodies for the reduction of anti-xenogeneic immune responses | |
AU2170692A (en) | Me20: monoclonal antibodies and antigen for human melanoma |